Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RheumMadness 2023: the All-Star Season

David L. Leverenz, MD, MEd  |  Issue: February 2023  |  February 13, 2023

FIGURE 1. (Click to enlarge.)

RheumMadness is back for its third season, and everyone who is crazy about rheumatology is welcome to play. That includes practicing rheumatologists, fellows, residents, medical students, advanced practice providers, other healthcare professionals and patients. Basically, if you are reading this article, you can play RheumMadness.

RheumMadness is an online tournament in which a bracket of teams, representing key learning concepts in rheumatology, compete against each other in a series of head-to-head match-ups, much like basketball teams in the NCAA (National Collegiate Athletic Association) March Madness tournament. Participants learn about these concept teams by reviewing scouting reports (i.e., topic summaries—created by dozens of rheumatology fellows and practicing rheumatologists).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

After learning about the concept teams, participants fill out their own brackets, attempting to predict the teams that will win each match-up. Playing RheumMadness is easy and free.

The true winners of each match-up are selected by consensus of a blue ribbon panel of judges based on its perception of which teams represent the most important, impactful and exciting concepts in the tournament. Participants get points when their picks match those of the blue ribbon panel, and the participants with the most correct predictions will be crowned the winners of RheumMadness.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

If that sounds confusing, don’t worry—we provide ample instructions along the way.

RheumMadness is supported by a Clinician Scholar Educator Award from the Rheumatology Research Foundation (Dr. Leverenz is principal investigator) and modeled after the NephMadness tournament in nephrology. To learn more, head to the RheumMadness website.

The All-Star Season

The theme of RheumMadness 2023 is the All-Star Season. Each of the 22 teams in the tournament is based on one all-star article competing to be named the most important and transformational article ever written in the field of rheumatology (see Figure 1). The teams represent a diverse array of manuscripts, from the earliest descriptions of rheumatic diseases to theories of basic immunologic mechanisms and some pivotal trials that fundamentally shifted treatment outcomes in rheumatology.

Fellows and attendings from 19 fellowship programs and two private practice groups chose these teams and created scouting reports to teach participants why they think each team has a chance to win it all. By engaging in this tournament, participants will have a chance to explore how the field of rheumatology developed into what it is today, gaining a deeper understanding of what it means to be a rheumatologist. Participants are challenged to press onward to even more transformational discoveries in the future.

Page: 1 2 3 | Single Page
Share: 

Filed under:Education & TrainingResearch Rheum Tagged with:FellowsFellows-in-Trainingonline educationRheumatology Research FoundationRheumMadness

Related Articles
    Tasha Art; PureSolution / shutterstock.com

    RheumMadness: An Educational Tournament

    July 15, 2021

    RheumMadness is an online collaborative learning experience created to educate trainees, rheumatologists and the wider medical community about recent advances and important concepts in rheumatology. The project is funded by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award and modeled after NephMadness, an educational initiative of the American Journal of Kidney Diseases (AJKD) that…

    Conversation: RheumMadness 2022 Reproductive Health Guide Scouting Report

    March 2, 2022

    Rheumatologists play a critical role in the reproductive health of their patients, but only half of rheumatologists currently ask their patients about reproductive health or family planning issues. A new guideline seeks to change that.

    An Oral Targeted Therapy: RheumMadness 2022 Pim Kinases Scouting Report

    February 8, 2022

    According to research, Pim kinases contribute to the pathogenesis of rheumatoid arthritis (RA) and may have the therapeutic potential for inhibition in patients with RA.

    Order in the Inflammatory Mess: RheumMadness 2022 Cytokine Networks Scouting Report

    February 8, 2022

    Research has identified and described a pro-inflammatory cytokine network shared by four rheumatic conditions that may be particularly active in patients with severe disease.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences